<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33332650</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2990</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Neuropathology and applied neurobiology</Title><ISOAbbreviation>Neuropathol Appl Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment.</ArticleTitle><Pagination><StartPage>544</StartPage><EndPage>563</EndPage><MedlinePgn>544-563</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/nan.12681</ELocationID><Abstract><AbstractText Label="AIM">Peroxisomes play a key role in lipid metabolism, and peroxisome defects have been associated with neurodegenerative diseases such as X-adrenoleukodystrophy and Alzheimer's disease. This study aims to elucidate the contribution of peroxisomes in lipid alterations of area 8 of the frontal cortex in the spectrum of TDP43-proteinopathies. Cases of frontotemporal lobar degeneration-TDP43 (FTLD-TDP), manifested as sporadic (sFTLD-TDP) or linked to mutations in various genes including expansions of the non-coding region of C9ORF72 (c9FTLD), and of sporadic amyotrophic lateral sclerosis (sALS) as the most common TDP43 proteinopathies, were analysed.</AbstractText><AbstractText Label="METHODS">We used transcriptomics and lipidomics methods to define the steady-state levels of gene expression and lipid profiles.</AbstractText><AbstractText Label="RESULTS">Our results show alterations in gene expression of some components of peroxisomes and related lipid pathways in frontal cortex area 8 in sALS, sFTLD-TDP and c9FTLD. Additionally, we identify a lipidomic pattern associated with the ALS-FTLD-TDP43 proteinopathy spectrum, notably characterised by down-regulation of ether lipids and acylcarnitine among other lipid species, as well as alterations in the lipidome of each phenotype of TDP43 proteinopathy, which reveals commonalities and disease-dependent differences in lipid composition.</AbstractText><AbstractText Label="CONCLUSION">Globally, lipid alterations in the human frontal cortex of the ALS-FTLD-TDP43 proteinopathy spectrum, which involve cell membrane composition and signalling, vulnerability against cellular stress and possible glucose metabolism, are partly related to peroxisome impairment.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Neuropathology and Applied Neurobiology published by John Wiley &amp; Sons Ltd on behalf of British Neuropathological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andr&#xe9;s-Benito</LastName><ForeName>Pol</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3000-0338</Identifier><AffiliationInfo><Affiliation>Neuropathology, Bellvitge University Hospital-Bellvitge Biomedical Research Institute (IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases, Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Initiative for Treatment and Research Initiative to Cure ALS (TRICALS, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelpi</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2948-4187</Identifier><AffiliationInfo><Affiliation>Neurological Tissue Bank of the Biobanc-Hospital Cl&#xed;nic-Institut d'Investigacions Biom&#xe8;diques August Pi I Sunyer (IDIBAPS, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Neurology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jov&#xe9;</LastName><ForeName>Mariona</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5577-6162</Identifier><AffiliationInfo><Affiliation>Department of Experimental Medicine, University of Lleida - Lleida Biomedical Research Institute (UdL-IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mota-Martorell</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5937-7070</Identifier><AffiliationInfo><Affiliation>Department of Experimental Medicine, University of Lleida - Lleida Biomedical Research Institute (UdL-IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obis</LastName><ForeName>&#xc8;lia</ForeName><Initials>&#xc8;</Initials><Identifier Source="ORCID">0000-0002-6838-1634</Identifier><AffiliationInfo><Affiliation>Department of Experimental Medicine, University of Lleida - Lleida Biomedical Research Institute (UdL-IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Portero-Otin</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1823-0299</Identifier><AffiliationInfo><Affiliation>Department of Experimental Medicine, University of Lleida - Lleida Biomedical Research Institute (UdL-IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Povedano</LastName><ForeName>M&#xf2;nica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>International Initiative for Treatment and Research Initiative to Cure ALS (TRICALS, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Functional Unit of Amyotrophic Lateral Sclerosis (UFELA, Service of Neurology, Bellvitge University Hospital, Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pujol</LastName><ForeName>Aurora</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9606-0600</Identifier><AffiliationInfo><Affiliation>Catalan Institution for Research and Advanced Studies (ICREA, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute, Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Research on Rare Diseases (CIBERER, Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pamplona</LastName><ForeName>Reinald</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-4337-6107</Identifier><AffiliationInfo><Affiliation>Department of Experimental Medicine, University of Lleida - Lleida Biomedical Research Institute (UdL-IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrer</LastName><ForeName>Isidro</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-9888-8754</Identifier><AffiliationInfo><Affiliation>Neuropathology, Bellvitge University Hospital-Bellvitge Biomedical Research Institute (IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases, Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Initiative for Treatment and Research Initiative to Cure ALS (TRICALS, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Neurosciences, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Neuropathol Appl Neurobiol</MedlineTA><NlmUniqueID>7609829</NlmUniqueID><ISSNLinking>0305-1846</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005625" MajorTopicYN="N">Frontal Lobe</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050356" MajorTopicYN="Y">Lipid Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="N">TDP-43 Proteinopathies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">fatty acid profiling</Keyword><Keyword MajorTopicYN="N">human frontal cortex</Keyword><Keyword MajorTopicYN="N">lipidomics</Keyword><Keyword MajorTopicYN="N">peroxisomes</Keyword><Keyword MajorTopicYN="N">plasmalogens</Keyword><Keyword MajorTopicYN="N">transcriptomics</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>17</Day><Hour>17</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33332650</ArticleId><ArticleId IdType="pmc">PMC8248144</ArticleId><ArticleId IdType="doi">10.1111/nan.12681</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>De Duve C, Baudhuin P. Peroxisomes (microbodies and related particles). Physiol Rev. 1996;46:323&#x2010;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">5325972</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen JI, Eggertsen G, Hellman U, Andersson U, Bj&#xf6;rkhem I. Molecular cloning and expression of cDNA encoding 3alpha, 7alpha,12alpha&#x2010;trihydroxy&#x2010;5beta&#x2010;chole stanoyl&#x2010;CoA oxidase from rabbit liver. J Biol Chem. 1997;272:18481&#x2010;18489.</Citation><ArticleIdList><ArticleId IdType="pubmed">9218493</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanders RJ, Waterham HR. Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem. 2006;75:295&#x2010;332.</Citation><ArticleIdList><ArticleId IdType="pubmed">16756494</ArticleId></ArticleIdList></Reference><Reference><Citation>Islinger M, Cardoso MJ, Schrader M. Be different&#x2014;the diversity of peroxisomes in the animal kingdom. Biochim Biophys Acta. 2010;1803:881&#x2010;887.</Citation><ArticleIdList><ArticleId IdType="pubmed">20347886</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanders RJ. Peroxisomes in human health and disease: metabolic pathways, metabolite transport, interplay with other organelles and signal transduction. Subcell Biochem. 2013;69:23&#x2010;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">23821141</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith JJ, Aitchinson JD. Peroxisomes take shape. Nat Rev Mol Cell Biol. 2013;14:803&#x2010;817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4060825</ArticleId><ArticleId IdType="pubmed">24263361</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodhi IF, Semenkovich CF. Peroxisomes: a nexus for lipid metabolism and cellular signalling. Cell Metab. 2014;19:380&#x2010;392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3951609</ArticleId><ArticleId IdType="pubmed">24508507</ArticleId></ArticleIdList></Reference><Reference><Citation>Islinger M, Voelkl A, Fahimi HD, Schrader M. The peroxisome: an update on mysteries 2.0. Histochem Cell Biol. 2018;150:443&#x2010;471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6182659</ArticleId><ArticleId IdType="pubmed">30219925</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker CL, Pomatto LCD, Tripathi DN, Davies KJA. Redox regulation of homeostasis and proteostasis in peroxisomes. Physiol Rev. 2018;98:89&#x2010;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6335096</ArticleId><ArticleId IdType="pubmed">29167332</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrader M, Costello JL, Godinho LF, Azadi AS, Islinger M. Proliferation and fission of peroxisomes &#x2010; an update. Biochim Biophys Acta. 2016;1863:971&#x2010;983.</Citation><ArticleIdList><ArticleId IdType="pubmed">26409486</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger J, Dorninger F, Forss&#x2010;Petter S, Kunze M. Peroxisomes in brain development and function. Biochim Biophys Acta. 2006;1863:934&#x2010;955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4880039</ArticleId><ArticleId IdType="pubmed">26686055</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu J, Ha CW, Zhang S, Jung JP, Huh WK, Liu P. Interactomic study on interaction between lipid droplets and mitochondria. Protein Cell. 2011;2:487&#x2010;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4875178</ArticleId><ArticleId IdType="pubmed">21748599</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zand A, Gent J, Braakman I, Tabak HF. Biochemically distinct vesicles from the endoplasmic reticulum fuse to form peroxisomes. Cell. 2012;149:397&#x2010;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">22500805</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrader M, Grille S, Fahimi HD, Islinger M. Peroxisome interactions and cross&#x2010;talk with other subcellular compartments in animal cells. Subcell Biochem. 2013;69:1&#x2010;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">23821140</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimitrov L, Lam SK, Schekman R. The role of the endoplasmic reticulum in peroxisome biogenesis. Cold Spring Harb Perspect Biol. 2013;5:a013243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3632059</ArticleId><ArticleId IdType="pubmed">23637287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanders RJA, Waterham HR, Ferdinandusse S. Metabolic interplay between peroxisomes and other subcellular organelles including mitochondria and the endoplasmic reticulum. Front Cell Develop Biol. 2016; 3: 83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4729952</ArticleId><ArticleId IdType="pubmed">26858947</ArticleId></ArticleIdList></Reference><Reference><Citation>Walther TC, Chung J, Farese RV. Lipid droplet biogenesis. Annu Rev Cell Dev Biol. 2017;33:491&#x2010;510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6986389</ArticleId><ArticleId IdType="pubmed">28793795</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YX. PPARs: diverse regulators in energy metabolism and metabolic diseases. Cell Res. 2010;20:124&#x2010;137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4084607</ArticleId><ArticleId IdType="pubmed">20101262</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrader M, Bonekamp NA, Islinger M. Fission and proliferation of peroxisomes. Biochim Biophys Acta. 2012;1822:1343&#x2010;1357.</Citation><ArticleIdList><ArticleId IdType="pubmed">22240198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadian M, Suh JM, Hah N, et al. PPARg signaling and metabolism: the good, the bad and the future. Nat Med. 2013;19:557&#x2010;566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3870016</ArticleId><ArticleId IdType="pubmed">23652116</ArticleId></ArticleIdList></Reference><Reference><Citation>Motley AM, Galvin PC, Ekal L, Nuttall JM, Hettema EH. Re&#x2010;evaluation of the role of Pex1 and dynamin&#x2010;related proteins in peroxisome membrane biogenesis. J Cell Biol. 2015;211:1041&#x2010;1056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4674274</ArticleId><ArticleId IdType="pubmed">26644516</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers JM, Moser HV. Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol. 1998;8:101&#x2010;120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8098283</ArticleId><ArticleId IdType="pubmed">9458170</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen GA, Wanders RJA, Watkins PA, Mihalik SJ. Phytanoyl&#x2010;coenzyme A hydroxylase deficiency&#x2014;the enzyme defect in Refsum's disease. N Engl J Med. 1997;337:133&#x2010;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">9221344</ArticleId></ArticleIdList></Reference><Reference><Citation>Faust PL, Banka D, Siriratsivawong R, Ng VG, Wikander TM. Peroxisome biogenesis disorders: the role of peroxisomes and metabolic dysfunction in developing brain. J Inherit Metab Dis. 2005;28:369&#x2010;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">15868469</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW. Peroxisome biogenesis disorders. Biochim Biophys Acta. 2006;1763:1733&#x2010;1748.</Citation><ArticleIdList><ArticleId IdType="pubmed">17055079</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferdinandusse S, Denis S, Mooyer PA, et al. Clinical and biochemical spectrum of D&#x2010;bifunctional protein deficiency. Ann Neurol. 2006;59: 92&#x2010;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">16278854</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferdinandusse S, Denis S, Hogenhout EM, et al. Clinical, biochemical, and mutational spectrum of peroxisomal acyl&#x2010;coenzyme A oxidase deficiency. Hum Mutat. 2007;28:904&#x2010;912.</Citation><ArticleIdList><ArticleId IdType="pubmed">17458872</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanders RJA, Ferdinandusse S, Brites P, Kemp S. Peroxisomes, lipid metabolism and lipotoxicity. Biochem Biophys Acta. 2010;1801:272&#x2010;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">20064629</ArticleId></ArticleIdList></Reference><Reference><Citation>Trompier D, Vejux A, Zarrouk A, et al. Brain peroxisomes. Biochimie. 2014;98:102&#x2010;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">24060512</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiki Y. Peroxisome biogenesis and human peroxisome&#x2010;deficiency disorders. Proc Jpn Acad Ser B. 2016;92:463&#x2010;477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5328784</ArticleId><ArticleId IdType="pubmed">27941306</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterham HR, Ferdinandusse S, Wanders RJA. Human disorders of peroxisome metabolism and biogenesis. Biochim Biophys Acta. 2016;1863:922&#x2010;933.</Citation><ArticleIdList><ArticleId IdType="pubmed">26611709</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano CR, Terlecky SR. Peroxisomes, cell senescence, and rates of aging. Biochim Biophys Acta. 2012;1822:1358&#x2010;1362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5047294</ArticleId><ArticleId IdType="pubmed">22497955</ArticleId></ArticleIdList></Reference><Reference><Citation>Fransen M, Nordgren M, Wang B, Apanasets O, Van Veldhoven PP. Aging, age&#x2010;related diseases and peroxisomes. Subcell Biochem. 2013;69:45&#x2010;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">23821142</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorninger F, Forss&#x2010;Petter S, Berger J. From peroxisomal disorders to common neurodegenerative diseases &#x2013; the role of ether phospholipids in the nervous system. FEBS Lett. 2017;591:2761&#x2010;2788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856336</ArticleId><ArticleId IdType="pubmed">28796901</ArticleId></ArticleIdList></Reference><Reference><Citation>Deori DM, Kale A, Maurya PK, Nagotu S. Peroxisomes: role in cellular ageing and age related disorders. Biogerontology. 2018;19:303&#x2010;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">29968207</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimini A, Moreno S, D&#x2019;Amelio M, et al. Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer&#x2019;s disease: a role for peroxisomes. J Alzheimers Dis. 2009;18:935&#x2010;952.</Citation><ArticleIdList><ArticleId IdType="pubmed">19749434</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanelli F, Sepe S, D&#x2019;Amelio M, et al. Age&#x2010;dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer&#x2019;s disease. Mol Neurodegener. 2013;8:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3599312</ArticleId><ArticleId IdType="pubmed">23374228</ArticleId></ArticleIdList></Reference><Reference><Citation>Igarashi M, Ma K, Gao F, Kim HW, Rapoport SI, Rao JS. Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer&#x2019;s disease prefrontal cortex. J Alzheimers Dis. 2011;24:507&#x2010;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3175096</ArticleId><ArticleId IdType="pubmed">21297269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kou J, Kovacs GG, Hoftberger R, et al. Peroxisomal alterations in Alzheimer&#x2019;s disease. Acta Neuropathol. 2011;122:271&#x2010;283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3168371</ArticleId><ArticleId IdType="pubmed">21594711</ArticleId></ArticleIdList></Reference><Reference><Citation>Searcy JL, Phelps JT, Pancani T, et al. Long&#x2010;term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease. J Alzheimers Dis. 2012;30:943&#x2010;961.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3378773</ArticleId><ArticleId IdType="pubmed">22495349</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbett GT, Gonzalez FJ, Pahan K. Activation of peroxisome proliferator&#x2010;activated receptor &#x3b1; stimulates ADAM10&#x2010;mediated proteolysis of APP. Proc Natl Acad Sci USA. 2015;112:8445&#x2010;8450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4500265</ArticleId><ArticleId IdType="pubmed">26080426</ArticleId></ArticleIdList></Reference><Reference><Citation>Vall&#xe9;e A, Lecarpentier Y. Alzheimer disease: crosstalk between the canonical Wnt/&#x3b2;&#x2010;catenin pathway and PPARs &#x3b1; and &#x3b3;. Front Neurosci. 2016;10:459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5069291</ArticleId><ArticleId IdType="pubmed">27807401</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva&#x2010;Abreu M, Calpena AC, Andr&#xe9;s&#x2010;Benito P, et al. PPAR&#x3b3; agonist&#x2010;loaded PLGA&#x2010;PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies. Int J Nanomed. 2018;13:5577&#x2010;5590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6154713</ArticleId><ArticleId IdType="pubmed">30271148</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Orio B, Fracassi A, Ceru MP, Moreno S. Targeting PPAR&#x3b1; in Alzheimer's disease. Curr Alzheimer Res. 2018;15:345&#x2010;354.</Citation><ArticleIdList><ArticleId IdType="pubmed">28474570</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MA, Alam Q, Haque A, et al. Current Progress on peroxisome proliferator&#x2010;activated receptor gamma agonist as an emerging therapeutic approach for the treatment of Alzheimer's disease: an update. Curr Neuropharmacol. 2019;17:232&#x2010;246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6425074</ArticleId><ArticleId IdType="pubmed">30152284</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2010;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586&#x2010;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">16116120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S&#x2010;C, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2010;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer I, Santpere G, Arzberger T, et al. Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe Study. J Neuropathol Exp Neurol. 2007;66:35&#x2010;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">17204935</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer I, Martinez A, Boluda S, Parchi P, Barrachina M. Brain banks: benefits, limitations and cautions concerning the use of post&#x2010;mortem brain tissue for molecular studies. Cell Tissue Bank. 2008;9:181&#x2010;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">18543077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer I. Selection of controls in the study of human neurodegenerative diseases in old age. J Neural Transm. 2015;122:941&#x2010;947.</Citation><ArticleIdList><ArticleId IdType="pubmed">25113170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer I. Brain banking. In: Aminoff MJ, Daroff RB, eds. Encyclopedia of the Neurological Sciences, 2nd ed. Vol. 1. Oxford: Academic Press; 2014;467&#x2010;473.</Citation></Reference><Reference><Citation>Mackenzie IR, Neumann M, Baborie A, et al. A harmonized classification system for FTLD&#x2010;TDP pathology. Acta Neuropathol. 2011;22:111&#x2010;113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285143</ArticleId><ArticleId IdType="pubmed">21644037</ArticleId></ArticleIdList></Reference><Reference><Citation>Hortobagyi T, Cairns NJ. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration. In: Kovacs Gabor G, ed. Neuropathology of Neurodegenerative Diseases: A Practical Guide. Cambridge: Cambridge University Press; 2015:209&#x2010;248.</Citation></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Irwin DJ, et al. Sequential distribution of pTDP&#x2010;43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol. 2014;127:423&#x2010;439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3971993</ArticleId><ArticleId IdType="pubmed">24407427</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabr&#xe9; R, Naud&#xed; A, Dominguez&#x2010;Gonzalez M, et al. Lipid profile in human frontal cortex is sustained throughout healthy adult life span to decay at advanced ages. J Gerontol A Biol Sci Med Sci. 2018;73:703&#x2010;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">28958038</ArticleId></ArticleIdList></Reference><Reference><Citation>Hancock SE, Friedrich MG, Mitchell TW, Truscott RJ, Else PL. The phospholipid composition of the human entorhinal cortex remains relatively stable over 80 years of adult aging. Geroscience. 2017;39:73&#x2010;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5352591</ArticleId><ArticleId IdType="pubmed">28299641</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrachina M, Casta&#xf1;o E, Ferrer I. TaqMan PCR assay in the control of RNA normalization in human post&#x2010;mortem brain tissue. Neurochem Int. 2006;49:276&#x2010;284.</Citation><ArticleIdList><ArticleId IdType="pubmed">16522342</ArticleId></ArticleIdList></Reference><Reference><Citation>Naud&#xed; A, Cabr&#xe9; R, Jov&#xe9; M, et al. Lipidomics of human brain aging and Alzheimer's disease pathology. Int Rev Neurobiol. 2015;122:133&#x2010;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">26358893</ArticleId></ArticleIdList></Reference><Reference><Citation>Caro P, Gomez J, Sanchez I, et al. Forty percent methionine restriction decreases mitochondrial oxygen radical production and leak at complex I during forward electron flow and lowers oxidative damage to proteins and mitochondrial DNA in rat kidney and brain mitochondria. Rejuv Res. 2009;12:421&#x2010;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">20041736</ArticleId></ArticleIdList></Reference><Reference><Citation>Naud&#xed; A, Cabr&#xe9; R, Dominguez&#x2010;Gonzalez M, et al. Region&#x2010;specific vulnerability to lipid peroxidation and evidence of neuronal mechanisms for polyunsaturated fatty acid biosynthesis in the healthy adult human central nervous system. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862:485&#x2010;495.</Citation><ArticleIdList><ArticleId IdType="pubmed">28185952</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillou H, Zadravec D, Martin PG, Jacobsson A. The key roles of elongases and desaturases in mammalian fatty acid metabolism: insights from transgenic mice. Prog Lipid Res. 2010;49:186&#x2010;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">20018209</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizarro C, Arenzana&#x2010;R&#xe1;mila I, P&#xe9;rez&#x2010;del&#x2010;Notario N, P&#xe9;rez&#x2010;Matute P, Gonz&#xe1;lez&#x2010;S&#xe1;iz JM. Plasma lipidomic profiling method based on ultrasound extraction and liquid chromatography mass spectrometry. Anal Chem. 2013;85:12085&#x2010;12092.</Citation><ArticleIdList><ArticleId IdType="pubmed">24266777</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradas I, Rovira&#x2010;Llopis S, Naud&#xed; A, et al. Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women. Sci Rep. 2019;9:16033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6831788</ArticleId><ArticleId IdType="pubmed">31690730</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn WB, Broadhurst D, Begley P, et al. Procedures for large&#x2010;scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6:1060&#x2010;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">21720319</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadhurst D, Begley P, Zelena E, et al. Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics. 2018;14:1&#x2010;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5960010</ArticleId><ArticleId IdType="pubmed">29805336</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez&#x2010;Alvarez MI, Sebasti&#xe1;n D, Vives S, et al. Deficient endoplasmic reticulum&#x2010;mitochondrial phosphatidylserine transfer causes liver disease. Cell. 2019;177:881&#x2010;895.</Citation><ArticleIdList><ArticleId IdType="pubmed">31051106</ArticleId></ArticleIdList></Reference><Reference><Citation>Koelmel JP, Kroeger N, Ulmer CZ, et al. LipidMatch: an automated workflow for rule&#x2010;based lipid identification using untargeted high&#x2010;resolution tandem mass spectrometry data. BMC Bioinformatics. 2017;18:331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5504796</ArticleId><ArticleId IdType="pubmed">28693421</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart DS, Feunang YD, Marcu A, et al. HMDB 4.0 &#x2014; the human metabolome database for 2018. Nucleic Acids Res. 2018;46:D608&#x2010;D617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5753273</ArticleId><ArticleId IdType="pubmed">29140435</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Z, Chong J, Li S, Xia J. MetaboAnalystR 3.0: toward an optimized workflow for global metabolomics. Metabolites. 2020;10:186.</Citation></Reference><Reference><Citation>Jov&#xe9; M, Pradas I, Dominguez&#x2010;Gonzalez M, Ferrer I, Pamplona R. Lipids and lipoxidation in human brain aging. Mitochondrial ATP&#x2010;synthase as a key lipoxidation target. Redox Biol. 2019;23:101082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6859548</ArticleId><ArticleId IdType="pubmed">30635167</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultana R, Perluigi M, Butterfield DA. Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med. 2013;62:157&#x2010;169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3573239</ArticleId><ArticleId IdType="pubmed">23044265</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnino S, Aureli M, Grassi S, Mauri L, Prioni S, Prinetti A. Lipid rafts in neurodegeneration and neuroprotection. Mol Neurobiol. 2014;50:130&#x2010;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">24362851</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood PL, Medicherla S, Sheikh N, et al. Targeted lipidomics of fontal cortex and plasma diacylglycerols (DAG) in mild cognitive impairment and Alzheimer's disease: validation of DAG accumulation early in the pathophysiology of Alzheimer's disease. J Alzheimers Dis. 2015;48:537&#x2010;546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4713833</ArticleId><ArticleId IdType="pubmed">26402017</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Han X. Advanced shotgun lipidomics for characterization of altered lipid patterns in neurodegenerative diseases and brain injury. Methods Mol Biol. 2016;1303:405&#x2010;422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4780753</ArticleId><ArticleId IdType="pubmed">26235081</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez&#x2010;Dom&#xed;nguez R, Garc&#xed;a&#x2010;Barrera T, G&#xf3;mez&#x2010;Ariza JL. Combination of metabolomic and phospholipid&#x2010;profiling approaches for the study of Alzheimer's disease. J Proteomics. 2014;104:37&#x2010;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">24473279</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Veldhoven PP. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J Lipid Res. 2010;51:2863&#x2010;2895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2936746</ArticleId><ArticleId IdType="pubmed">20558530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp S, Wanders R. Biochemical aspects of X&#x2010;linked adrenoleukodystrophy. Brain Pathol. 2010;20:831&#x2010;837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8094824</ArticleId><ArticleId IdType="pubmed">20626744</ArticleId></ArticleIdList></Reference><Reference><Citation>Sastry PS. Lipids of nervous tissue: composition and metabolism. Prog Lipid Res. 1985;24:69&#x2010;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">3916238</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X. Neurolipidomics: challenges and developments. Front Biosci. 2007;12:2601&#x2010;2615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2141543</ArticleId><ArticleId IdType="pubmed">17127266</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouser G, Galli C, Kritchevsky G. Lipid class composition of normal human brain and variations in metachromatic leukodystrophy, Tay&#x2010;Sachs, Niemann&#x2010;Pick, Chronic Gaucher&#x2019;s and Alzheimer&#x2019;s diseases. J Am Oil Chem Soc. 1965;42:404&#x2010;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">14324330</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien JS, Sampson EL. Lipid composition of the normal human brain: gray matter, white matter, and myelin. J Lipid Res. 1965;6:537&#x2010;544.</Citation><ArticleIdList><ArticleId IdType="pubmed">5865382</ArticleId></ArticleIdList></Reference><Reference><Citation>Panganamala RV, Horrocks LA, Geer JC, Cornwell DG. Positions of double bonds in the monounsaturated alk&#x2010;1&#x2010;enyl groups from the plasmalogens of human heart and brain. Chem Phys Lipids. 1971;6:97&#x2010;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">5557221</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando S, Chang NC, Yu RK. High&#x2010;performance thin&#x2010;layer chromatography and densitometric determination of brain ganglioside compositions of several species. Anal Biochem. 1978;89:437&#x2010;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">103458</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrill AH Jr, Sullards MC, Allegood JC, Kelly S, Wang E. Sphingolipidomics: high&#x2010;throughput, structure&#x2010;specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods. 2005;36:207&#x2010;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">15894491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosicek M, Hecimovic S. Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers. Int J Mol Sci. 2013;14:1310&#x2010;1322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3565322</ArticleId><ArticleId IdType="pubmed">23306153</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanno K, Wu MK, Scapa EF, Roderick SL, Cohen DE. Structure and function of phosphatidylcholine transfer protein (PC&#x2010;TP)/StarD2. Biochim Biophys Acta. 2007;1771:654&#x2010;662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743068</ArticleId><ArticleId IdType="pubmed">17499021</ArticleId></ArticleIdList></Reference><Reference><Citation>Farine L, Niemann M, Schneider A, B&#xfc;tikofer P. Phosphatidylethanolamine and phosphatidylcholine biosynthesis by the Kennedy pathway occurs at different sites in Trypanosoma brucei. Sci Rep. 2015;5:16787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4649479</ArticleId><ArticleId IdType="pubmed">26577437</ArticleId></ArticleIdList></Reference><Reference><Citation>Exton JH. Signaling through phosphatidylcholine breakdown. J Biol Chem. 1990;65:1&#x2010;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">2104616</ArticleId></ArticleIdList></Reference><Reference><Citation>Billah MM, Anthes JC. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem J. 1990;269:281&#x2010;291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1131573</ArticleId><ArticleId IdType="pubmed">2201284</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagone P, Jackowski S. Phosphatidylcholine and the CDP&#x2010;choline cycle. Biochim Biophys Acta. 2013;1831:523&#x2010;532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3562404</ArticleId><ArticleId IdType="pubmed">23010477</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone SJ, Vance JE. Cloning and expression of murine liver phosphatidylserine synthase (PSS)&#x2010;2: differential regulation of phospholipid metabolism by PSS1 and PSS2. Biochem J. 1999;342:57&#x2010;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1220436</ArticleId><ArticleId IdType="pubmed">10432300</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Vance DE. Phosphatidylcholine and choline homeostasis. J Lipid Res. 2008;9:1187&#x2010;1194.</Citation><ArticleIdList><ArticleId IdType="pubmed">18204095</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanznaster D, Bourgeais J, Bruno C, et al. TDP&#x2010;43&#x2010;mediated toxicity in HEK293T cells: a fast and reproducible protocol to be employed in the search of new therapeutic options against amyotrophic lateral sclerosis. Cells. 2019;9:68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7016571</ArticleId><ArticleId IdType="pubmed">31888078</ArticleId></ArticleIdList></Reference><Reference><Citation>Arima H, Omura T, Hayasaka T, et al. Reductions of docosahexaenoic acid&#x2010;containing phosphatidylcholine levels in the anterior horn of an ALS mouse model. Neuroscience. 2015;297:127&#x2010;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">25841322</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean JM, Lodhi IJ. Structural and functional roles of ether lipids. Protein Cell. 2018;9:196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5818364</ArticleId><ArticleId IdType="pubmed">28523433</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallner S, Schmitz G. Plasmalogens the neglected regulatory and scavenging lipid Species. Chem Phys Lipids. 2011;164:573&#x2010;589.</Citation><ArticleIdList><ArticleId IdType="pubmed">21723266</ArticleId></ArticleIdList></Reference><Reference><Citation>Braverman NE, Moser AB. Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta &#x2010; Mol Basis Dis. 2012;1822:1442&#x2010;1452.</Citation><ArticleIdList><ArticleId IdType="pubmed">22627108</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldfine H. The appearance, disappearance and reappearance of plasmalogens in evolution. Prog Lipid Res. 2010;49:493&#x2010;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">20637230</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh K, Martins RN, Meikle PJ. Lipidomic profiles in diabetes and dementia. J Alzheimers Dis. 2017;59:433&#x2010;444.</Citation><ArticleIdList><ArticleId IdType="pubmed">28582856</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahy E, Subramaniam S, Murphy R, et al. Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res. 2009;50:S9&#x2010;S14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2674711</ArticleId><ArticleId IdType="pubmed">19098281</ArticleId></ArticleIdList></Reference><Reference><Citation>Posse de Chaves E, Sipione S. Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett. 2010;584:1748&#x2010;1759.</Citation><ArticleIdList><ArticleId IdType="pubmed">20006608</ArticleId></ArticleIdList></Reference><Reference><Citation>Trayssac M, Hannun YA, Obeid LM. Role of sphingolipids in senescence: implication in aging and age&#x2010;related diseases. J Clin Invest. 2018;128:2702&#x2010;2712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6025964</ArticleId><ArticleId IdType="pubmed">30108193</ArticleId></ArticleIdList></Reference><Reference><Citation>Rietveld A, Simons K. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim Biophys Acta. 1998;1376:467&#x2010;479.</Citation><ArticleIdList><ArticleId IdType="pubmed">9805010</ArticleId></ArticleIdList></Reference><Reference><Citation>Meikle PJ, Summers SA. Sphingolipids and phospholipids in insulin resistance and related metabolic disorders. Nat Rev Endocrinol. 2017;13:79&#x2010;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">27767036</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannun YA, Obeid LM. Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol. 2018;19:175&#x2010;191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5902181</ArticleId><ArticleId IdType="pubmed">29165427</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n V, Fabelo N, Santpere G, et al. Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex. J Alzheimers Dis. 2010;19:489&#x2010;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">20110596</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabelo N, Mart&#xed;n V, Santpere G, et al. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease. Mol Med. 2011;17:1107&#x2010;1118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3188884</ArticleId><ArticleId IdType="pubmed">21717034</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin R, Fabelo N, Mart&#xed;n V, et al. Anomalies occurring in lipiod profiles and protein distribution in frontal cortex lipoid rafts in dementia with Lewy bodies disclose neurochemical traits partailly shared by Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease. Neurobiol Aging. 2017; 49:52&#x2010;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">27768960</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az M, Fabelo N, Ferrer I, Mar&#xed;n R. "Lipid raft aging" in the human frontal cortex during nonpathological aging: gender influences and potential implications in Alzheimer's disease. Neurobiol Aging. 2018;67:42&#x2010;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">29627763</ArticleId></ArticleIdList></Reference><Reference><Citation>Houten SM, Wanders RJA, Ranea&#x2010;Robles P. Metabolic interactions between peroxisomes and mitochondria with a special focus on acylcarnitine metabolism. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146961</ArticleId><ArticleId IdType="pubmed">32057943</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuda O, Brezinova M, Silhavy J, et al. Nrf2&#x2010;mediated antioxidant defense and peroxiredoxin 6 are linked to biosynthesis of palmitic acid ester of 9&#x2010;hydroxystearic acid. Diabetes. 2018;67:1190&#x2010;1199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463562</ArticleId><ArticleId IdType="pubmed">29549163</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>